An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers
Call us @: 844 663-3742
Study Details
Medical Condition
Study Phase
Intervention Type
Date
Participation Requirements
Gender
Age
Healthy Volunteers
Inclusion Criteria
Exclusion Criteria
Have a question?
You can ask us questions via online form or phone call.
Call us @: 844 663-3742
| Location | Status | Site Contact Details |
|---|---|---|
Location Healthy Volunteer Site 1, Fair Lawn, New Jersey, 07410 | Status Not Available |
This is Part 1 of a two-part, randomized, double-blind, placebo-controlled study in which VTP-43742 was administered to participants; Part 1 in healthy volunteers and Part 2 in psoriatic participants.
Number of participants with treatment-emergent adverse events (TEAEs) in the healthy volunteer (Part 1) group
Time Frame: Study Day 1 to Day 17±2 (follow up)
Maximum plasma concentration (Cmax) in the healthy volunteer (Part 1) group
Time Frame: Day 1 and Day 10
Time to maximum plasma concentrations (tmax) in the healthy volunteer (Part 1) group
Time Frame: Day 1 and Day 10
The area under the plasma concentration versus time curve, from time 0 to the last measurable concentration (AUCt) in the healthy volunteer (Part 1) group
Time Frame: Day 1 and Day 10
Half life (t½) in the healthy volunteer (Part 1) group
Time Frame: Day 10 to Day 13 (72 hours)
Interventions:
- Drug: Placebo
- Drug: VTP-43742
- Drug: VTP-43742
- Drug: VTP-43742
- Drug: VTP-43742
- Drug: VTP-43742
Enrollment:
40
Additional Information
Watch a video to learn more about what you may experience as a clinical trial volunteer: /resources/what-happens-in-a-clinical-trial
Take a virtual reality screening visit tour to an example of a clinical trial site: /resources/screening-visit-virtual-tour
Use a questionnaire tool to think through questions to ask yourself about participating in a clinical trial and print out your responses to discuss with your partners in your health journey: /resource-information-clinical-trial-community/decision-counselor